136 related articles for article (PubMed ID: 10454042)
1. Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection.
Shah S; Qaqish R; Patel V; Amiji M
J Pharm Pharmacol; 1999 Jun; 51(6):667-72. PubMed ID: 10454042
[TBL] [Abstract][Full Text] [Related]
2. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
Hejazi R; Amiji M
Int J Pharm; 2002 Mar; 235(1-2):87-94. PubMed ID: 11879743
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach.
Patel VR; Amiji MM
Pharm Res; 1996 Apr; 13(4):588-93. PubMed ID: 8710751
[TBL] [Abstract][Full Text] [Related]
4. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
Erah PO; Goddard AF; Barrett DA; Shaw PN; Spiller RC
J Antimicrob Chemother; 1997 Jan; 39(1):5-12. PubMed ID: 9044021
[TBL] [Abstract][Full Text] [Related]
5. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
Patel JK; Patel MM
Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
[TBL] [Abstract][Full Text] [Related]
6. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
Thombre NA; Gide PS
Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pH triggers in situ porous controlled release micro balloon delivery of amoxicillin for eradication of Helicobacter pylori.
Tripathi GK; Singh S; Nath G; Dubey RK
Curr Drug Deliv; 2011 Nov; 8(6):667-77. PubMed ID: 22313162
[TBL] [Abstract][Full Text] [Related]
8. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.
Ishak RA; Awad GA; Mortada ND; Nour SA
J Control Release; 2007 Jun; 119(2):207-14. PubMed ID: 17412443
[TBL] [Abstract][Full Text] [Related]
9. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.
Wang J; Tauchi Y; Deguchi Y; Morimoto K; Tabata Y; Ikada Y
Drug Deliv; 2000; 7(4):237-43. PubMed ID: 11195431
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin.
Sahasathian T; Praphairaksit N; Muangsin N
Arch Pharm Res; 2010 Jun; 33(6):889-99. PubMed ID: 20607494
[TBL] [Abstract][Full Text] [Related]
11. Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils.
Hejazi R; Amiji M
Pharm Dev Technol; 2003 Aug; 8(3):253-62. PubMed ID: 12901691
[TBL] [Abstract][Full Text] [Related]
12. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
13. [Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Gisbert JP; Boixeda D; de Rafael L; Redondo C; Martín de Argila C; Bermejo F
Rev Esp Enferm Dig; 1996 May; 88(5):317-22. PubMed ID: 8764537
[TBL] [Abstract][Full Text] [Related]
14. Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
Adebisi AO; Conway BR
Int J Pharm; 2014 Aug; 470(1-2):28-40. PubMed ID: 24792977
[TBL] [Abstract][Full Text] [Related]
15. Design, Optimization, and Evaluation of a Novel Metronidazole-Loaded Gastro-Retentive pH-Sensitive Hydrogel.
El-Mahrouk GM; Aboul-Einien MH; Makhlouf AI
AAPS PharmSciTech; 2016 Dec; 17(6):1285-1297. PubMed ID: 26689404
[TBL] [Abstract][Full Text] [Related]
16. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
Patel JK; Chavda JR
J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
[TBL] [Abstract][Full Text] [Related]
19. [The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
Tian XL; Zhang JZ; Zhou LY; Geng QM; Han YJ
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):604-7. PubMed ID: 22041275
[TBL] [Abstract][Full Text] [Related]
20. A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation.
Hao S; Wang Y; Wang B; Zou Q; Zeng H; Chen X; Liu X; Liu J; Yu S
Int J Pharm; 2014 Mar; 463(1):10-21. PubMed ID: 24406672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
